GlucoTrack Valuation
| GCTK Stock | USD 0.25 0.01 3.85% |
GlucoTrack seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of GlucoTrack from evaluating the firm fundamentals such as Shares Owned By Insiders of 34.97 %, return on equity of -5.41, and Return On Asset of -1.57 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting GlucoTrack's valuation include:
Price Book 21.403 | Enterprise Value 3.9 M | Enterprise Value Ebitda (1.01) |
Overvalued
Today
Please note that GlucoTrack's price fluctuation is out of control at this time. Calculation of the real value of GlucoTrack is based on 3 months time horizon. Increasing GlucoTrack's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
GlucoTrack's intrinsic value may or may not be the same as its current market price of 0.25, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.25 | Real 0.24 | Hype 0.17 | Naive 0.56 |
The intrinsic value of GlucoTrack's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence GlucoTrack's stock price.
Estimating the potential upside or downside of GlucoTrack helps investors to forecast how GlucoTrack stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GlucoTrack more accurately as focusing exclusively on GlucoTrack's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use GlucoTrack's intrinsic value based on its ongoing forecasts of GlucoTrack's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against GlucoTrack's closest peers.
GlucoTrack Cash |
|
GlucoTrack Valuation Trend
Knowing GlucoTrack's actual value is paramount for traders when making sound investment determinations. Using both GlucoTrack's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
GlucoTrack Total Value Analysis
GlucoTrack is currently anticipated to have valuation of 3.95 M with market capitalization of 2.04 M, debt of 196 K, and cash on hands of 3.85 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the GlucoTrack fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.95 M | 2.04 M | 196 K | 3.85 M |
GlucoTrack Asset Utilization
One of the ways to look at asset utilization of GlucoTrack is to check how much profit was generated for every dollar of assets it reports. GlucoTrack retains a negative application of resources of -1.57 (percent), losing $0.0157 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of GlucoTrack shows how discouraging it operates for each dollar spent on its resources.GlucoTrack Ownership Allocation
GlucoTrack secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.GlucoTrack Profitability Analysis
Net Loss for the year was (7.1 M) with loss before overhead, payroll, taxes, and interest of (20 K).About GlucoTrack Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of GlucoTrack. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of GlucoTrack based exclusively on its fundamental and basic technical indicators. By analyzing GlucoTrack's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of GlucoTrack's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of GlucoTrack. We calculate exposure to GlucoTrack's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GlucoTrack's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -13 K | -12.3 K | |
| Pretax Profit Margin | (19.37) | (20.34) | |
| Operating Profit Margin | 15.11 | 14.36 | |
| Net Loss | (19.37) | (20.34) | |
| Gross Profit Margin | 0.87 | 0.91 |
GlucoTrack Growth Indicators
Investing in growth stocks can be very risky. If the company such as GlucoTrack does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.2 M |
GlucoTrack Current Valuation Indicators
GlucoTrack's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final GlucoTrack's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GlucoTrack, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GlucoTrack's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GlucoTrack's worth.When determining whether GlucoTrack is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlucoTrack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glucotrack Stock. Highlighted below are key reports to facilitate an investment decision about Glucotrack Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Return On Assets (1.57) | Return On Equity (5.41) |
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.